Trial Details

COMPLETED
Basic Information
Clinical ID c1124
Identifier NCT01020708
Trial Title Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: mesalamine|DRUG: ALTH12-1:4|DRUG: ALTH12-2:4
Participant Information
Sponsor Altheus Therapeutics, Inc.
City Oklahoma City
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-11-09
Primary Completion Date 2025-09-10
Completion Date 2025-09-10